Skip to main content

Animations

MJFF Publications

5491 - 5500 of 7915 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • OPEN
    Title: Cognitive Profiles and Hub Vulnerability in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2018.00482
    Citation Count: 37
  • RESTRICTED
    Title: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034
    Best OA location URL:
    Citation Count: 11
  • RESTRICTED
    Title: Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0198166
    Citation Count: 83
  • OPEN
    Title: Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy157
    Citation Count: 64
  • RESTRICTED
    Title: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236
    Best OA location URL:
    Citation Count: 7
  • OPEN
    Title: Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysis
    Journal Name: BMC Genomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12864-018-4804-9
    Citation Count: 38
  • OPEN
    Title: Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation
    Journal Name: Journal of Alzheimer's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-180121
    Citation Count: 86
  • OPEN
    Title: Dual role of USP 30 in controlling basal pexophagy and mitophagy
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745595
    Citation Count: 126
  • RESTRICTED
    Title: Tau-targeting therapies for Alzheimer disease
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-018-0013-z
    Citation Count: 726
  • OPEN
    Title: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s models
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4
    Citation Count: 126
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.